文献速递甲状腺与颈部外科

甲状腺切除术中自体荧光检测甲状旁腺对术后甲状旁腺激素水平的影响:平行多中心随机临床试验

Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial.
PubMed 文献 · Br J Surg · 2023-01-01

这项平行多中心随机对照试验比较了甲状腺全切除术中使用Fluobeam® LX通过自体荧光显影甲状旁腺与不使用该技术,主要终点为术后第1天甲状旁腺激素(PTH)水平降低的发生率。共随机535例,486例按方案接受干预(Fluobeam® LX组246例,对照组240例)。全组低PTH发生率两组无显著差异,但在中央区淋巴结清扫亚组中Fluobeam® LX组低PTH发生率显著低于对照组。

要点

  • Fluobeam® LX组术后第1天低PTH发生率为26.0%,对照组为32.1%(P=0.141;RR 0.81,95%CI 0.61-1.07),全组无显著差异。
  • 中央区淋巴结清扫亚组中,Fluobeam® LX组低PTH发生率为18%(15/82),对照组为33%(31/92)(P=0.021;RR 0.54,95%CI 0.31-0.93)。
  • 使用Fluobeam® LX术中识别出更多甲状旁腺,且最终组织病理学标本中甲状旁腺更少;未报告与该设备使用相关的特定伤害。

核心结论

  • 在全组患者中,甲状腺切除术中使用自体荧光并未降低术后第1天低PTH水平的发生率,但在一个亚组患者中降低了该发生率。

研究设计与样本

  • 平行多中心随机对照试验,比较甲状腺全切除术中使用Fluobeam® LX通过自体荧光显影甲状旁腺与不使用,手术指征无限制,患者按1:1随机分组并对分组设盲。
  • 共随机535例患者,486例按研究方案接受干预,其中Fluobeam® LX组246例,对照组240例。
  • 主要终点为术后第1天低甲状旁腺激素(PTH)水平的发生率。
  • 试验注册号:NCT04509011。

主要发现

  • Fluobeam® LX组64例(26.0%)和对照组77例(32.1%)术后低PTH水平(P=0.141;相对风险(RR)0.81,95%CI 0.61-1.07)。
  • 中央区淋巴结清扫的174例患者亚组分析中,Fluobeam® LX组82例中15例(18%)和对照组92例中31例(33%)术后第1天低PTH水平(P=0.021;RR 0.54,95%CI 0.31-0.93)。
  • 使用Fluobeam® LX手术的患者术中识别出更多甲状旁腺,且最终组织病理学标本中甲状旁腺更少。
  • 未报告与Fluobeam® LX使用相关的特定伤害。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Techniques for autofluorescence have been introduced to visualize the parathyroid glands during surgery and to reduce hypoparathyroidism after thyroidectomy. METHODS: This parallel multicentre RCT investigated the use of Fluobeam® LX to visualize the parathyroid glands by autofluorescence during total thyroidectomy compared with no use. There was no restriction on the indication for surgery. Patients were randomized 1 : 1 and were blinded to the group allocation. The hypothesis was that autofluorescence enables identification and protection of the parathyroid glands during thyroidectomy. The primary endpoint was the rate of low parathyroid hormone (PTH) levels the day after surgery. RESULTS: Some 535 patients were randomized, and 486 patients received an intervention according to the study protocol, 246 in the Fluobeam® LX group and 240 in the control group. Some 64 patients (26.0 per cent) in the Fluobeam® LX group and 77 (32.1 per cent) in the control group had low levels of PTH after thyroidectomy (P = 0.141; relative risk (RR) 0.81, 95 per cent c.i. 0.61 to 1.07). Subanalysis of 174 patients undergoing central lymph node clearance showed that 15 of 82 (18 per cent) in the Fluobeam® LX group and 31 of 92 (33 per cent) in the control group had low levels of PTH on postoperative day 1 (P = 0.021; RR 0.54, 0.31 to 0.93). More parathyroid glands were identified during operation in patients who had surgery with Fluobeam® LX, and fewer parathyroid glands in the surgical specimen on definitive histopathology. No specific harm related to the use of Fluobeam® LX was reported. CONCLUSION: The use of autofluorescence during thyroidectomy did not reduce the rate of low PTH levels on postoperative day 1 in the whole group of patients. It did, however, reduce the rate in a subgroup of patients. Registration number: NCT04509011 (http://www.clinicaltrials.gov).

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Bergenfelz A, Barczynski M, Heie A, et al. Impact of autofluorescence for detection of parathyroid glands during thyroidectomy on postoperative parathyroid hormone levels: parallel multicentre randomized clinical trial. Br J Surg. 2023. PMID: 37758507. doi:10.1093/bjs/znad278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。